Detalles de la búsqueda
1.
Overcoming Lot-to-Lot Variability in Protein Activity Using Epitope-Specific Calibration-Free Concentration Analysis.
Anal Chem
; 96(16): 6275-6281, 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38600735
2.
Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease.
Nat Genet
; 40(9): 1107-12, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19165925
3.
2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral & Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry (Part 2 - Recommendations on Biomarkers/CDx Assays Development & Validation, Cytometry Validation & Innovation, Biotherapeutics PK LBA Regulated Bioanalysis, Critical Reagents & Positive Controls Generation).
Bioanalysis
; 14(10): 627-692, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35578974
4.
Validation of preclinical pharmacokinetic and immunogenicity assays for an anti-PCSK9 antibody.
J Immunoassay Immunochem
; 32(4): 296-317, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21728822
5.
Strategies for method comparison when changes in the immunogenicity method are needed within a clinical program.
Bioanalysis
; 12(7): 431-443, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343147
6.
Development of CAPER peptides for the treatment of triple negative breast cancer.
Cell Cycle
; 19(4): 432-447, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31931653
7.
Generic Anti-PEG Antibody Assay on ProterixBio's (Formerly BioScale) ViBE Platform Shows Poor Reproducibility.
AAPS J
; 20(3): 65, 2018 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29691672
8.
Accelerating Regulated Bioanalysis for Biotherapeutics: Case Examples Using a Microfluidic Ligand Binding Assay Platform.
AAPS J
; 19(1): 82-91, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27796911
9.
Development of a Generic Anti-PEG Antibody Assay Using BioScale's Acoustic Membrane MicroParticle Technology.
AAPS J
; 17(6): 1511-6, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26139446
10.
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3--LBA, biomarkers and immunogenicity).
Bioanalysis
; 7(24): 3107-24, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26635247
11.
Addressing matrix effects in ligand-binding assays through the use of new reagents and technology.
Bioanalysis
; 6(8): 1059-67, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24830890
12.
Evaluation of acoustic membrane microparticle (AMMP) technology for a sensitive ligand binding assay to support pharmacokinetic determinations of a biotherapeutic.
AAPS J
; 16(6): 1366-71, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25245223
13.
Development and validation of an LC-MS/MS assay for the quantitation of a PEGylated anti-CD28 domain antibody in human serum: overcoming interference from antidrug antibodies and soluble target.
Bioanalysis
; 6(18): 2371-83, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25384590
14.
An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genes.
Int J Biol Sci
; 8(3): 310-27, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22355267
15.
Choosing the right bioanalytical assay platform(s) to support the PK assessment of protein biotherapeutic programs.
Bioanalysis
; 7(10): 1197-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26045001
16.
Pharmacokinetic immunoassay methods in the presence of soluble target.
J Immunol Methods
; 361(1-2): 75-81, 2010 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-20696169
17.
Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease.
Nat Genet
; 41(12): 1341-4, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19935662
Resultados
1 -
17
de 17
1
Próxima >
>>